Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH) today. The company’s shares closed last Monday at $14.19, close to its 52-week low of $13.09.
According to TipRanks.com, Belanger is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -7.3% and a 29.7% success rate. Belanger covers the Healthcare sector, focusing on stocks such as KalVista Pharmaceuticals, Collegium Pharmaceutical, and Zynerba Pharmaceuticals.
The the analyst consensus on Amphastar Pharmaceuticals is currently a Hold rating.
See today’s analyst top recommended stocks >>
The company has a one-year high of $23.06 and a one-year low of $13.09. Currently, Amphastar Pharmaceuticals has an average volume of 222.6K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments.
